Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy

British Journal of Cancer

Volumn 73, Issue 1, 1996, Pages 73-78

  Bogden, A E ^a   LePage, D ^a   Zwicker, S ^a   Grant, W ^a   Silver, M ^a  

^a Biomeasure Inc   (United States)

Author keywords

Inhibiting proliferative response; Lanreotide; Proliferative response; Prostatic trauma; Somatostatin; Transurethral resection of the prostate controversy

Indexed keywords

ANGIOPEPTIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SURGERY; SURGICAL INJURY; SURGICAL RISK; TRANSURETHRAL RESECTION; TUMOR XENOGRAFT;

EID: 0030027729     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.13     Document Type: Article

References (39)

1. AGATSTEIN EH, HERNANDEZ FJ, LAYFIELD LJ, SMITH RB AND DEKERNION JB. (1987). Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: A clinical trial. J. Urol., 138, 551-553.
2. AMDUR RJ, PARSONS JT, FITZGERALD LT AND MILLION RR. (1990). Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up. Radiother. Oncol., 18, 235-246.
3. ANSCHER MS AND PROSNITZ LR. (1991). Transurethral resection of prostate prior to definitive irradiation for prostate cancer. Lack of correlation with treatment outcome. Urology, 38, 206-211.
4. BLUTE ML, ZINCKE H AND FARROW GM. (1986). Long-term follow-up of young patients with stage A adenocarcinoma of the prostate. J. Urol., 136, 840-843.
5. BOGDEN AE, MOREAU J-P, LEPAGE D, ZWICKER S, SILVER M, GRANT W AND SBI A. (1993). Inhibiting the surgical trauma induced proliferative surge of in situ tumors with a somatostatin analogue (Lanreotide). Proc. Am. Assoc. Cancer Res., 34, 229.
6. COPLEN DE, ANDRIOLE GL, YUAN JJ AND CATALONA WJ. (1991). The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hypertrophy. J. Urol., 146, 75-77.
7. DENTON SE, CHOY SH AND VALK WL. (1965). Occult prostatic carcinoma diagnosed by the step section technique of the surgical specimen. J. Urol., 93, 296-298.
8. EHRLICH P. (1908). Referat über die genese des carcinoms. Verhandl.d.deutsch. path. Gesselsch., 12, 13-32.
9. EPSTEIN JI, PAULL G, EGGLESTON JC AND WALSH PC. (1986). Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow-up. J. Urol., 136, 837-840.
10. FISHER B, GUNDUZ N, COYLE J, RUDOCK C AND SAFFER E. (1989). Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res., 49, 1996-2001.
11. FORMAN JD, ORDER SE, ZINREICH ES, LEE DJ, WHARAM MD AND MELLITS ED. (1986). The correlation of pretreatment transurethral resection of prostatic cancer with tumor dissemination and disease-free survival. Cancer, 58, 1770-1778.
12. HAMMARSTEN J, ANDERSSON S, HOLMÉN A, HÖGSTEDT B AND PEEKER R. (1994). Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? Cancer, 74, 2347-2351.
13. HANKS GE, LEIBEL S AND KRAMER S. (1983). The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J. Urol., 129, 309-311.
14. HANKS GE, PILEPICH MV, KRALL JM, SAUSE WT, JOHNSON RJ, RUSS HH, PEREZ CA, SINNIGER M AND MARTZ KL. (1986). The adverse effect of TURP as method of diagnosis in 494 patients with stage C prostate cancer treated within RTOG protocol 75-106 (abstract 30). Int. J. Radiat. Oncol. Biol. Phys., 12, (suppl 1), 106.
15. HEIMAN ML, MURPHY WA AND COY DH. (1987). Differential binding of somatostatin agonists to brain and adenohypophysis. Neuroendocrinology, 45, 429-436.
16. JOHANSSON JE, ADAMI H-O, ANDERSSON S-O, BERGSTRÖM RB, HOLMBERG L AND KRUSEMO UB. (1992). High 10 year survival rate in patients with early, untreated prostatic cancer. JAMA, 267, 2191-2196.
17. KUBAN DA, EL-MAHDI AM AND SCHELLHAMMER PF. (1987). The effect of TURP on prognosis in prostatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 13, 1653-1659.
18. LOWE BA AND LISTROM MB. (1988). Incidental carcinoma of the prostate: an analysis of the predictors of progression. J. Urol., 140, 1340-1344.
19. MCGOWAN DG. (1980). The adverse influence of prior transurethral resection on prognosis in carcinoma of prostate treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 6, 1121-1126.
20. MCGOWAN DG. (1988). The effect of transurethral resection on prognosis in carcinoma of the prostate: real or imaginary? Int. J. Radiat. Oncol. Biol. Phys., 15, 1057-1064.
21. MCGOWAN DG. (1987). The effect of transurethral resection on prognosis in carcinoma of the prostate: real or imaginary? Int. J. Radiat. Oncol. Biol. Phys., 13, 1653-1659.
22. MCNEAL JE. (1993). Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer. Cancer, 71, 984-991.
23. MARIE P AND CLUNET J. (1910). Fréquence de métastases viscérales chez les souris cancereuses après ablation chirurgicale de leur tumeur. Bull. Assoc. Franc. p. l'etude du cancer, 3, 19-23.
24. PAGE BH. (1980). The pathological anatomy of digital enucleation for benign prostatic hyperplasia and its application to endoscopie resection. Br. J. Urol., 52, 111-126.
25. PEREZ CA, GARCIA D, SIMPSON JR, ZIVNUSKA F AND LOCKETT MA. (1989). Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother. Oncol., 16, 1-21.
26. RIGGINS RS AND KETCHAM AS. (1965). Effect of incisional biopsy on the development of experimental tumor metastases. J. Surg. Res., 5, 200-206.
27. ROMSDAHL MM. (1964). Influence of surgical procedures on development of spontaneous lung metastases. J. Surg. Res., 4, 363-370.
28. RUDENSTAM CM. (1968). Experimental studies on trauma and metastasis formation. Acta Chir. Scand., 391, (suppl.), 1-83.
29. SCHATTEN WE. (1958). An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor. Cancer, 11, 455-459.
30. SCHWARTZ I, WEIN AJ, MALLOY TR AND GLICK JH. (1986). Prostatic cancer after prostatectomy for benign disease. Cancer, 58, 944-996.
31. SCOTT R JR, MUTCHNIK DL, LASKOWSKI TZ AND SCHMALHORST WR. (1969). Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J. Urol., 101, 602-607.
32. SHELDON CA, WILLIAMS RD AND FRALEY EE. (1980). Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J. Urol., 124, 626-631.
33. SILVERBERG E AND LUBERA JA. (1989). Cancer statistics. Cancer, 39, 3-20.
34. SIMPSON-HERREN L, SANFORD AH AND HOLMQUIST JP. (1974). Cell population kinetics of transplanted and metastatic Lewis lung carcinoma. Cell Tissue Kinet., 7, 349-361.
35. SIMPSON-HERREN L, SANDFORD AH AND HOLMQUIST JP. (1976). Effects of surgery on the cell kinetics of residual tumor. Cancer Treat. Rep., 60, 1749-1760.
36. SMITH GG AND WOODRUFF LM. (1950). Development of cancer of prostate after subtotal prostatectomy. J. Urol., 63, 1077-1080.
37. TYZZER EE. (1913). Factors in production and growth of tumor metastales. J. Med. Res., 28, 309-322.
38. WALSH PC. (1980). Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol. Clin. N. Am., 7, 583-591.
39. ZAGARS GK, VON ESCHENBACH AC AND AYALA AG. (1993). Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer, 72, 1709-1725.